Pieter C. Limburg

Groningen, GR, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

Antigen-Specific Detection of Autoantibodies Against Myeloperoxidase (MPO) and Proteinase 3 (PR3).

Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 13, 2018

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Autoantibodies to box A of high mobility group box 1 in systemic lupus erythematosus.

Journal: Clinical and experimental immunology
Published: February 23, 2017

Identification of Lifelines participants at high risk for development of rheumatoid arthritis.

Identification of Lifelines participants at high risk for development of rheumatoid arthritis.

Journal: Annals of the rheumatic diseases
Published: February 15, 2017

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.

Presence of anticitrullinated protein antibodies in a large population-based cohort from the Netherlands.

Journal: Annals of the rheumatic diseases
Published: May 31, 2016

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.

High mobility group box 1 skews macrophage polarization and negatively influences phagocytosis of apoptotic cells.

Journal: Rheumatology (Oxford, England)
Published: December 15, 2015

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice.

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice.

Journal: Molecular medicine (Cambridge, Mass.)
Published: July 29, 2015

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

Are urinary levels of high mobility group box 1 markers of active nephritis in anti-neutrophil cytoplasmic antibody-associated vasculitis?

Journal: Clinical and experimental immunology
Published: July 20, 2014

Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.

Impact of serum high mobility group box 1 and soluble receptor for advanced glycation end-products on subclinical atherosclerosis in patients with granulomatosis with polyangiitis.

Journal: PloS one
Published: December 06, 2013

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

High mobility group box1 (HMGB1) in relation to cutaneous inflammation in systemic lupus erythematosus (SLE).

Journal: Lupus
Published: April 04, 2013

Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).

Increased frequency of circulating IL-21 producing Th-cells in patients with granulomatosis with polyangiitis (GPA).

Journal: Arthritis research & therapy
Published: January 16, 2013

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

Journal: Arthritis research & therapy
Published: December 04, 2012

Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Urinary CD8+ T-cell counts discriminate between active and inactive lupus nephritis.

Journal: Arthritis research & therapy
Published: August 19, 2012
Showing 1-12 of 14

Last Updated: 09/26/2026